Canada markets closed

Alliance Pharma plc (APH.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
37.25-0.40 (-1.06%)
At close: 04:35PM BST

Alliance Pharma plc

Avonbridge House
Bath Road
Chippenham SN15 2BB
United Kingdom
44 12 4946 6966
https://www.alliancepharmaceuticals.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees285

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew Timothy FranklinInterim CEO, CFO & Executive Director271.52kN/A1966
Mr. Peter Jonathan ButterfieldCEO & Executive Director (Leave of Absence)399.83kN/A1976
Mr. Jeyan Heper (Hons), BACOO & DirectorN/AN/A1974
Mr. Stephen KidnerChief Scientific Affairs OfficerN/AN/AN/A
Ms. Cora Maeve McCallum C.F.A.Head of Investor Relations & Corporate CommunicationsN/AN/AN/A
Mr. Christodoulos Theoclis ChrysanthouGroup General Counsel & Company SecretaryN/AN/AN/A
Mr. Alex DugganChief Commercial & Corporate Development OfficerN/AN/AN/A
Julie SkinnerChief People OfficerN/AN/AN/A
Chris DelafieldGlobal Marketing Head of Kelo-CoteN/AN/AN/A
Rhodri SmithHead of SourcingN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

Corporate Governance

Alliance Pharma plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.